Tersmette M - Search Results

1

HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.

Boucher CA, Lange JM, Miedema FF, Weverling GJ, Koot M, Mulder JW, Goudsmit J, Kellam P, Larder BA, Tersmette M. Boucher CA, et al. Among authors: tersmette m. AIDS. 1992 Nov;6(11):1259-64. doi: 10.1097/00002030-199211000-00003. AIDS. 1992. PMID: 1282015

2

Biphasic rate of CD4+ cell count decline during progression to AIDS correlates with HIV-1 phenotype.

Schellekens PT, Tersmette M, Roos MT, Keet RP, de Wolf F, Coutinho RA, Miedema F. Schellekens PT, et al. Among authors: tersmette m. AIDS. 1992 Jul;6(7):665-9. doi: 10.1097/00002030-199207000-00008. AIDS. 1992. PMID: 1354447

3

HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.

Koot M, Vos AH, Keet RP, de Goede RE, Dercksen MW, Terpstra FG, Coutinho RA, Miedema F, Tersmette M. Koot M, et al. Among authors: tersmette m. AIDS. 1992 Jan;6(1):49-54. doi: 10.1097/00002030-199201000-00006. AIDS. 1992. PMID: 1543566

4

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population.

Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M. Schuitemaker H, et al. Among authors: tersmette m. J Virol. 1992 Mar;66(3):1354-60. doi: 10.1128/JVI.66.3.1354-1360.1992. J Virol. 1992. PMID: 1738194 Free PMC article.

5

Immunological and virological markers in individuals progressing from seroconversion to AIDS.

Gruters RA, Terpstra FG, De Goede RE, Mulder JW, De Wolf F, Schellekens PT, Van Lier RA, Tersmette M, Miedema F. Gruters RA, et al. Among authors: tersmette m. AIDS. 1991 Jul;5(7):837-44. doi: 10.1097/00002030-199107000-00007. AIDS. 1991. PMID: 1892588

6

Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy.

Boucher CA, Tersmette M, Lange JM, Kellam P, de Goede RE, Mulder JW, Darby G, Goudsmit J, Larder BA. Boucher CA, et al. Among authors: tersmette m. Lancet. 1990 Sep 8;336(8715):585-90. doi: 10.1016/0140-6736(90)93391-2. Lancet. 1990. PMID: 1975378

7

Interactions between HIV and the host immune system in the pathogenesis of AIDS.

Tersmette M, Miedema F. Tersmette M, et al. AIDS. 1990;4 Suppl 1:S57-66. AIDS. 1990. PMID: 2152587 Review. No abstract available.

8

Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality.

Tersmette M, Lange JM, de Goede RE, de Wolf F, Eeftink-Schattenkerk JK, Schellekens PT, Coutinho RA, Huisman JG, Goudsmit J, Miedema F. Tersmette M, et al. Lancet. 1989 May 6;1(8645):983-5. doi: 10.1016/s0140-6736(89)92628-7. Lancet. 1989. PMID: 2565516

9

Viral phenotype and T cell reactivity in human immunodeficiency virus type 1-infected asymptomatic men treated with zidovudine.

Koot M, Schellekens PT, Mulder JW, Lange JM, Roos MT, Coutinho RA, Tersmette M, Miedema F. Koot M, et al. Among authors: tersmette m. J Infect Dis. 1993 Sep;168(3):733-6. doi: 10.1093/infdis/168.3.733. J Infect Dis. 1993. PMID: 8102631 Clinical Trial.

10

Immunological and virological markers determining progression to AIDS.

Schellekens PT, Koot M, Roos MT, Tersmette M, Miedema F. Schellekens PT, et al. Among authors: tersmette m. Neth J Med. 1994 Dec;45(6):238-43. Neth J Med. 1994. PMID: 7838238 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters